WATCH: J&J vaccine concerns over Delta variant

A new study has revealed that the Johnson and Johnson vaccine is less effective against the Delta variant of COVID-19. The study suggests the need for a second dose for the millions of people who have already received the jab. Critical-care professor at Wits University, Guy Richards, gives analysis #eNCA Courtesy #DStv403

JOHANNESBURG - A new American laboratory study has revealed that the Johnson & Johnson vaccine is less effective against the Delta variant of COVID-19.

The study suggests a second dose will be needed for the millions of people who have already received the jab.

READ: Lack of vaccines for Africa 'unacceptable': World Bank

Nearly 480,000 healthcare workers in the country have received the jab as part of the Sisonke trial

Critical-care professor at Wits University, Guy Richards, says there is no need to worry.

Watch the video above for more details on this story

Source
eNCA

Paid Content